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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYHematopoietic stem andprogenitor cells (HSPCs) are born fromhemogenic endothelium in the dorsal aorta. Specification of this hemato-
poietic niche is regulated by a signaling axis using Hedgehog (Hh) and Notch, which culminates in expression of Runx1 in the ventral
wall of the artery. Here, we demonstrate that the vitamin D precursor cholecalciferol (D3) modulates HSPC production by impairing he-
mogenic vascular niche formation. Accumulation of D3 through exogenous treatment or inhibition of Cyp2r1, the enzyme required for
D3 25-hydroxylation, results in Hh pathway antagonismmarked by loss of Gli-reporter activation, defects in vascular niche identity, and
reduced HSPCs. Mechanistic studies indicated the effect was specific to D3, and not active 1,25-dihydroxy vitamin D3, acting on the
extracellular sterol-binding domain of Smoothened. These findings highlight a direct impact of inefficient vitamin D synthesis on cell
fate commitment and maturation in Hh-regulated tissues, which may have implications beyond hemogenic endothelium specification.INTRODUCTION
Hematopoietic stem cells (HSCs) have the lifelong ability
to self-renew and generate each of the blood lineages. In
vertebrates, definitive hematopoiesis begins with de novo
birth of HSCs from hemogenic endothelium along the
ventral wall of the dorsal aorta in a conserved region
known as the aorta-gonad-mesonephros (AGM) (Dzierzak
and Medvinsky, 2008). Studies in zebrafish and mammals
have demonstrated that formation of the hematovascular
niche is dependent on a signaling cascade between the
Hedgehog (Hh) and the Notch pathways. This signaling
controls placement of the stem cell leukemia (SCL) tran-
scription factor and induction of the first definitive HSC
marker, Runx1 (Gering and Patient, 2005; Kim et al.,
2013; Lawson et al., 2002). Based on the conserved role
of runx1 in zebrafish (Burns et al., 2005; Kissa and Herbo-
mel, 2010; North et al., 2002), we previously performed a
chemical screen to identify regulators of HSC production
(North et al., 2007). We recently showed cholesterol-
derived estrogens have a crucial role in establishing hemo-
genic endothelium boundaries (Carroll et al., 2014); the
cholesterol derivative vitamin D was likewise identified
as a candidate hematopoietic stem and progenitor cell
(HSPC) regulator in the screen.
VitaminD synthesis begins with the transformation of 7-
dehydrocholesterol in the skin by UV radiation to generate
the non-active vitamin D precursor cholecalciferol (D3).
Some vertebrates, including teleosts (e.g., zebrafish), obtain
D3 primarily from their diet (Lock et al., 2010). D3 is
modified by the cytochrome P450 enzyme 2R1 (CYP2R1)
to generate 25-hydroxy vitamin D (25(OH)D3), theStem Cellcirculating form of vitamin D, which is then further
hydroxylated by CYP27B1 to generate the active vitamin
D metabolite, 1,25-dihydroxy vitamin D3 (1,25(OH)D3).
Active 1,25(OH)D3 functions as the ligand for the vitamin
D receptor (VDR), a member of the nuclear hormone recep-
tor family, resulting in nuclear localization and transcrip-
tional regulation (Plum andDeLuca, 2010). Ligand binding
also induces non-genomic cellular responses, including
calcium uptake (Norman, 2006). Zebrafish exhibit strong
conservation of the vitamin D biosynthetic pathway and
its downstream signaling cascade (Craig et al., 2008; Lin
et al., 2012).
Beyond the established role of 1,25(OH)D3 in VDR
signaling, the biological function of vitamin D precursors
in mediating non-VDR dependent events remains contro-
versial. Mutations in 7-dehydrocholesterol reductase are
associated with Hh defects in mammals (Koide et al.,
2006). Cell culture studies designed to isolate cholesterol
derivatives affecting Hh signaling identified 3beta-hydrox-
ysteroids, including D3, as negative Hh regulators in C3H/
10T1/2 fibroblasts (Bijlsma et al., 2006). This study and
others indicated exogenous addition of D3 may block Hh
activity in a VDR-independent manner, potentially at the
level of Smoothened (Bijlsma et al., 2006; Tang et al.,
2011). Beyond these preliminary analyses, the mechanism
of action of potential D3-mediated Hh regulation remains
unclear and in vivo physiological relevance has not been
elucidated.
Here, we demonstrate that exposure to elevated D3 (12–
24 hours post fertilization [hpf]) negatively regulates hem-
atovascular niche specification, decreasing HSPC numbers
while sparing the gross development of the dorsal aorta. D3Reports j Vol. 5 j 471–479 j October 13, 2015 j ª2015 The Authors 471
inhibits the Hh signaling axis via binding in vivo to the
recently described extracellular sterol-binding domain of
Smoothened. Likewise, physiological accumulation of D3
mediated by inhibition of cyp2r1 significantly reduced Hh
activity and disrupted hemogenic niche specification, lead-
ing to low HSPCs. Together, these in vivo studies indicate
inefficient vitamin D synthesis affects cellular specification
and tissue maturation in the embryo, independent of re-
ductions in 1,25(OH)D3 content, via negative regulation
of the Hh signaling pathway.RESULTS
Vitamin D Metabolites Differentially Regulate
Definitive Hematopoiesis
Vitamin D was isolated in a prior chemical screen in zebra-
fish as a potential modulator of HSPC gene expression
(North et al., 2007). To characterize the impact of vitamin
D on definitive hematopoiesis, zebrafish embryos were
exposed to the non-hydroxylated vitamin D precursor D3
and the active hydroxylated vitamin D metabolite,
1,25(OH)D3, between 12 and 36 hpf during the onset
of HSPC formation. Treatment with D3 decreased expres-
sion of conserved HSPC markers runx1 and cmyb as deter-
mined by whole-mount in situ hybridization (WISH) at
36 hpf (Figures 1A and 1B) and reduced HSPC-reporter
(Tg(runx1P2:eGFP)) activity in the AGM (Figure 1C). In
contrast, 1,25(OH)D3 increased both runx1/cmyb expres-
sion and Runx1 reporter activity (Figures 1A–1C), suggest-
ing distinctmodes of action. To confirm and quantify these
findings, fluorescence-activated cell sorting (FACS) analysis
was performed using Tg(lmo2:dsRed);Tg(cmyb:gfp) embryos,
highlighting a broad population of HSPCs: D3 caused a
25% (p < 0.01) decrease, while 1,25(OH)D3 elicited a 20%
(p < 0.01) increase in HSPC numbers (Figure 1D). To eluci-
date the cause of the differential regulation, embryos were
treated for select intervals during hemogenic vascular
endothelium specification (12–24 hpf) or definitive HSPC
production (24–36 hpf). Whereas 1,25(OH)D3 increased
runx1/cmyb WISH expression during either treatment win-
dow, the negative effect of D3was predominantly observed
with exposure between 12 and 24 hpf (Figures 1E and 1F).
qPCR confirmed that statistically significant reductions in
runx1 were seen only after early D3 treatment, indicative
of an effect on the HSPC niche (Figure S1A). However,
analysis of flk1 expression indicated vasculogenesis was
not grossly altered (Figure S1B). Early D3 exposure also
had a minimal effect on the expression of cyp24a1, a direct
VDR transcriptional target, while 1,25(OH)D3was a potent
activator (Figure S1C). Together, these data suggest D3 af-
fects HSPC production via VDR-independent alterations
in vascular niche specification.472 Stem Cell Reports j Vol. 5 j 471–479 j October 13, 2015 j ª2015 The AD3 Exposure Inhibits Hh-Notch-Mediated Hemogenic
Niche Specification
In vertebrates, HSCs are born from hemogenic endothe-
lium specified by highly orchestrated signaling events start-
ing with the Hh pathway and ending with Notch activity
(Carroll et al., 2014; Kim et al., 2013; Lawson et al.,
2002). Based on this pivotal role in vascular niche specifica-
tion and prior studies describing potential inhibitory ef-
fects of D3, we hypothesized that D3 accumulation
affected HSPC formation via inhibition of the Hh-Notch
signaling cascade. To determine whether D3 could act to
antagonize Hh-regulated developmental processes in vivo,
the Tg(gli-d:mcherry) reporter line was used (Schwend et al.,
2010). D3-treated embryos showed reducedGli-reporter ac-
tivity in the trunk region as determined by WISH (Figures
2A and 2B), similar to that seen with the Hh inhibitor cy-
clopamine. Co-treatment caused more severe inhibition,
suggesting synergistic Hh antagonism (Figures 2A and
2B). FACS analysis of whole embryo disaggregates revealed
a 54% (p < 0.01) decrease in total Gli-reporter-positive
cells by D3 treatment alone and a 91% (p < 0.001) loss in
combination with cyclopamine (Figure 2C). In contrast,
no reduction in Hh activity was observed following
1,25(OH)D3 treatment by Gli-reporter WISH or FACS (Fig-
ures S2A and S2B). To confirm the effect of D3was indepen-
dent of VDR signaling, a previously validated morpholino
(MO) was employed (Lin et al., 2012). No significant
changes in Gli-reporter expression were seen with vdra
knockdown (Figures S2C and S2D); however, morphants
exposed to D3 still had reduced Hh activity (Figure 2D),
supporting an alternate mechanism of action.
Consistent with a role for Hh upstream of Notch in
vascular specification, D3 also diminished Notch-reporter
activity (Tg(EPV.Tp1CMmu.Hbb:EGFP)) in the trunk vessels
by WISH (Figures 2E and 2F), which was exacerbated by
cyclopamine. D3-treated embryos had an expanded region
of venous identity marked by flt4 and concomitant de-
creases in arterial fate as indicated by ephrinb2a (Figure S2E),
consistent with published reports (Lawson et al., 2002; Car-
roll et al., 2014). Reductions in arterial ephrinb2a and notch3
(Figure S2F), and the Hh target ptc1, with D3 exposure were
confirmed by qRT-PCR. In contrast, neither addition of
1,25(OH)D3 nor vdra MO affected vascular niche and Hh
target expression (Figures S2G and S2H). Finally, scl+hemo-
genic endothelium was profoundly lost in D3-treated
embryos (Figures 2G and 2H), confirming disruption of
the most proximal specification event downstream of Hh-
Notch signaling to HSPCs.
20(S)-OHC Rescues D3-Mediated Inhibition of
Smoothened and Hh Activity
The G-coupled protein receptor Smoothened was previ-
ously identified as the target of cyclopamine-mediateduthors
Figure 1. Vitamin D Metabolites Have Differential Effects on HSC Formation
(A) Exposure to D3 (50 mM) decreased runx1/cmyb expression by WISH at 36 hpf, and 1,25(OH)D3 (10 mM) increased expression. Scale bar,
100 mm.
(B) Qualitative phenotypic distribution of embryos from (A) scored with low, medium, or high runx1/cmyb expression in the AGM (n > 50
embryos/condition).
(C) Runx1:GFP embryos exhibited either diminished or enhanced expression with D3 or 1,25(OH)D3 exposure, respectively. Scale bar,
100 mm.
(D) FACS analysis of double-positive HSPCs in Lmo2:dsRed/cMyb:GFP embryos confirmed a 25% (*p = 0.014) decrease with D3
versus a 20% (**p = 0.029) increase with 1,25(OH)D3 compared to controls (5 embryos/sample 3 4 replicates/condition). Error bars,
mean ± SD.
(E) D3 treatment during hemogenic niche specification (12–24 hpf) or HSC induction (24–36 hpf) only decreased runx1/cmyb by WISH in
the early exposure window, whereas 1,25(OH)D3 increased expression during either treatment period. Scale as in (A).
(F) Qualitative phenotypic distribution of embryos from (E) scored for runx1/cmyb as in (B) (n > 20 embryos/condition).
See also Figure S1.Hh pathway inhibition; prior in vitro data suggested D3
may antagonize the same target (Bijlsma et al., 2006). Oxy-
sterols, which stimulate Hh signaling (Corcoran and Scott,
2006), were recently shown to bind in the extracellular
cysteine-rich domain (CRD) of Smoothened, distinct
from the heptahelical pocket cyclopamine targets (Nedelcu
et al., 2013). To elucidate the mechanism of action of D3
on Hh activity in vivo, D3-treated embryos were exposed
to Smoothened agonists SAG and 20(S)-hydroxycholes-
terol (20(S)-OHC) (Figure 3A). SAG binds to the heptaheli-
cal bundle, and can directly compete with cyclopamineStem Cell(Chen et al., 2002), whereas 20(S)-OHC binds the N-termi-
nal extracellular CRD (Nedelcu et al., 2013). Co-treatment
with SAG failed to block D3-mediated Hh inhibition as
seen byGli-reporter FACS (Figure 3B). In contrast, exposure
to 20(S)-OHC preserved Hh signaling in the presence of
D3 (p < 0.05) (Figure 3B). Co-exposure to 20(S)-OHC also
restored ptc2 and runx1 expression in D3-treated embryos
by qRT-PCR (p < 0.005) (Figure 3C), as well as HSPC induc-
tion by WISH (Figures 3D and 3E). These data indicate D3
inhibits Hh-dependent hemogenic endothelium specifica-
tion in vivo by interactions with the Smoothened CRD.Reports j Vol. 5 j 471–479 j October 13, 2015 j ª2015 The Authors 473
Figure 2. D3 Negatively Regulates Hh-Mediated Vascular Niche Specification
(A) Gli:mCherry expression was decreased in D3-treated embryos compared to controls by WISH. Cyclopamine co-treatment caused syn-
ergistic reduction. Scale bar, 200 mm.
(B) Qualitative phenotypic distribution of embryos from (A) scored for gli:mcherry (n > 20 embryos/condition).
(C) Gli:mCherry FACS showed significant decreases in Hh responsive cells in D3 (54%, *p = 0.006), cyclopamine (70%, **p = 0.001), or co-
treated embryos (91%,***p = 0.001) (5 embryos/sample 3 4 replicates/condition). Error bars, mean ± SD.
(D) Qualitative phenotypic distribution of gli:mcherry expression in vdra morphants occurred in the presence or absence of D3 treatment
(n > 20 embryos/condition).
(E) D3 reduced Notch reporter activity in intersomitic and axial vessels, similar to cyclopamine, by WISH. Co-treatment exacerbated Notch
inhibition. Scale bar, 100 mm.
(F) Qualitative phenotypic distribution of embryos from (D) scored for Notch-GFP (n > 20 embryos/condition).
(G) SCL-GFP embryos treated with D3 (12–30 hpf) had reduced scl+ hemogenic endothelium by WISH for GFP. Scale as in (E).
(H) Qualitative phenotypic distribution of embryos from (F) scored for scl:GFP (n > 10 embryos/condition).
See also Figure S2.Loss of cyp2r1 Negatively Affects Hh Activity via D3/
Smoothened Antagonism
Vitamin D synthesis begins concurrently with the onset
of definitive hematopoiesis, as cyp2r1 (25-hydroxylase),
cyp27b1 (1-hydroxylase), and cyp24a1 (24-hydroxylase)
are actively transcribed in the embryo by 24 hpf (Fig-
ure S3A). Mutations in CYP2R1, which catalyzes the first
hydroxylation step in the enzymatic processing of D3 to
1,25(OH)D3, are associated with human vitamin D defi-
ciency. To determine the potential physiological relevance
of cyp2r1 mutation-mediated D3 accumulation on Hh-de-474 Stem Cell Reports j Vol. 5 j 471–479 j October 13, 2015 j ª2015 The Apendent hematovascular specification, embryos deficient
in cyp2r1 were created by the clustered regularly inter-
spaced short palindromic repeat (CRISPR)-CRISPR-associ-
ated 9 (Cas9) system (Jao et al., 2013). An allele with a
25-base pair deletion in exon 3, predicted to encode a
truncated protein with a severely compromised active
site, was produced (Figures S3B and S3C). Targeted dele-
tion of cyp2r1 diminished runx1 expression (50% pene-
trance) compared to sibling controls (Figure 4A) while
leaving flk1+ vasculature grossly normal (Figure 4B). To
confirm and quantify these observations, a cyp2r1 MOuthors
Figure 3. D3 Antagonizes Hh Signaling via Interaction with the Extracellular Domain of Smoothened
(A) Diagram depicts the sites of action of Hh pathway modifiers cyclopamine, SAG, and 20-OHC on the Smoothened receptor. The pre-
sumptive site of D3 action (red) is shown.
(B) FACS of Gli-reporter embryos showed D3 decreased Hh activity (*p = 0.002). SAG co-treatment (5 mM) did not alter the effect of
D3, while 20(S)-OHC (10 mM) partially blocked Hh inhibition (**p = 0.040) (5 embryos/sample 3 4 replicates/condition). Error bars,
mean ± SD.
(C) Co-treatment with 20(S)-OHC corrected D3-mediated reductions in ptc2 (*p = 0.019) and runx1 (**p = 0.003) by qPCR (40 pooled
embryos/condition 3 3 replicates). Error bars, mean ± SD.
(D) 20(S)-OHC restored runx1 expression in D3-treated embryos. Scale bar, 100 mm.
(E) Qualitative phenotypic distribution of embryos from (D) scored for runx1 (n > 20 embryos/condition).was employed (Figures S3D and S3E). Morphants had a
similar decrease in runx1/cmyb expression to that of
cyp2r1 mutants (Figures 4C and 4D), with FACS indicating
a 21% (p < 0.05) reduction in Flk1:dsRed+/cMyb:GFP+
HSCs (Figure 4E). Consistent with diminished Hh
signaling due to D3 accumulation, cyp2r1 mutants ex-
hibited substantially reduced ptc2 expression (77% pene-
trance) (Figure 4F). These effects were validated by Gli-
reporter WISH following cyp2r1-MO knockdown (Figures
4G and 4H) and quantified as a 33% (p < 0.01) decrease
in Hh activity by FACS (Figure 4I). The cyp2r1 morphants
also had reduced Notch-reporter activity (Figures S4A and
S4B) and artery or vein defects (Figures S4C and S4D), as
seen with D3 exposure. In contrast, no inhibitory effect
was seen in embryos injected with a MO to cyp27b1 (Fig-
ures S4E–S4G), further indicating that D3 accumulation,
rather than loss of 1,25(OH)D3, caused the Hh pheno-
types. To confirm the specificity of Cyp2r1 function inStem CellHh regulation, morphants were co-injected with full-
length zebrafish cyp2r1 mRNA, mitigating the Gli-reporter
phenotype (Figure 4J). Finally, to corroborate Smoothened
antagonism, as found for D3, morphant embryos were
treated with 20(S)-OHC and Gli-reporter activity was
restored (Figure 4K). In sum, these data show that physio-
logically relevant reductions in vitamin D biosynthesis,
occurring at the level of D3 hydroxylation via cyp2r1 mu-
tation, negatively affect Hh-dependent processes like hem-
atovascular specification in vivo by accumulation of D3
and direct inhibition of the Smoothened CRD.DISCUSSION
Beyond the role of vitamin D in calcium homeostasis, se-
vere vitamin D deficiency in humans is associated with a
variety of hematopoietic disorders, including anemia andReports j Vol. 5 j 471–479 j October 13, 2015 j ª2015 The Authors 475
Figure 4. Cyp2r1 Inhibition and Failed
D3 Hydroxylation Elicits Hh-Related De-
fects in HSPC Production
(A) WISH for runx1 showed cyp2r1 mutation
results in HSPC defects. Scale bar, 100 mm.
(B) WISH for flk1 revealed minimal impact of
cyp2r1 loss on trunk vessels. Scale as in (A).
(C) cyp2r1 morphants had diminished
runx1/cmyb expression. Scale bar, 50 mm.
(D) Qualitative phenotypic distribution of
embryos from (C) scored for runx1 (n > 30
embryos/condition).
(E) Flk:dsRed+/cMyb:GFP+ FACS indicated a
21%(*p=0.0328) decrease inHSCs in cyp2r1
morphants (5 embryos/sample 3 4 repli-
cates/condition). Error bars, mean ± SD.
(F) In cyp2r1 mutants, ptc2 WISH showed
Hh signaling was affected by endogenous
D3 accumulation (77% penetrance). Scale
as in (A).
(G) WISH for Gli-reporter expression in
cyp2r1morphants confirmed low Hh activity
was correlated with ineffective D3 hydrox-
ylation. Scale bar, 100 mm.
(H) Qualitative phenotypic distribution
of embryos from (G) scored for mcherry
expression (n > 40 embryos/condition).
(I) FACS of cyp2r1-MO-injected Gli-reporter
embryos revealed a 33% (*p = 0.0065)
decrease in Hh activity (n value and error
bars as in E).
(J) Gli:mCherry FACS showed co-injection of
zebrafish cyp2r1 mRNA-rescued, cyp2r1-MO-
meditated decreases in Hh activity (*p =
0.009) (n value and error bars as in E).
(K) 20(s)-OHC-rescued defects in Hh activ-
ity caused by cyp2r1 knockdown as shown
by FACS of the Gli-reporter line (*p =
0.0005) (n value and error bars as in E).
See also Figures S3 and S4.extramedullary hematopoiesis (Yetgin et al., 1989), due
to alterations in the bone marrow microenvironment.
VDR-deficient mice likewise display extramedullary hema-
topoiesis (Jeanson and Scadden, 2010). Vitamin D is also
important in the immune system, specifically affecting
T cell development and function (Kongsbak et al., 2013).
Despite these findings, there is minimal investigation
into the role of vitamin D regulation in the earliest stages
of hematopoiesis. In this study, we demonstrate that
vitamin D precursor D3 affects hemogenic vascular niche
specification, affecting HSPC numbers during embryogen-
esis. Excess D3 derived from exogenous exposure or
insufficient Cyp2r1 function diminished Hh signaling
and disrupted Hh-regulated mesodermal cell fate. Signifi-
cantly, these effects were not phenocopied by 1,25(OH)476 Stem Cell Reports j Vol. 5 j 471–479 j October 13, 2015 j ª2015 The AD3 or dependent on VDR activity. Rather, our data indi-
cate that D3 acts directly on Smoothened at the recently
defined extracellular sterol-binding domain (Figure 3A).
The strong synergy observed between D3 and cyclop-
amine toward Hh inhibition in vivo is consistent with
prior mechanistic studies in which 20(S)-OHC and SAG
mediated allosteric interactions between the CRD and
the heptahelical binding domains of Smoothened to result
in maximum pathway activation (Nachtergaele et al.,
2012). Finally, the cyp2r1 loss-of-function studies demon-
strate a physiological role for D3 in Hh pathway inhibi-
tion. These findings are intriguing in the context of
human disease, because CYP2R1 mutations result in
vitamin D-deficient rickets marked by skeletal abnormal-
ities, with low levels of 25(OH)D3 but relatively normaluthors
levels of 1,25(OH)D3 (Al Mutair et al., 2012). While it has
been postulated that maintenance of 1,25(OH)D3 suffi-
ciency is due to increased parathyroid hormone activity
and alterations in CYP27B1 and CYP24A1 function, it
will be important to re-evaluate whether developmental
abnormalities in these patients are partially due to reduc-
tions in Hh signaling caused by D3 accumulation. It
will also be interesting to examine interplay between
abnormal vitamin D biosynthesis and Hh signaling in can-
cer, specifically in tissues where both pathways intersect.
In summary, we elucidated the physiological conse-
quences of abnormal vitamin D biosynthesis at the level
of D3 hydroxylation on hematovascular specification
and characterized the mechanism of action in vivo as an
antagonistic interaction of D3 with Smoothened and the
Hh signaling pathway.EXPERIMENTAL PROCEDURES
Zebrafish Husbandry
Zebrafish were maintained in accordance with the Beth Israel
Deaconess Medical Center Institutional Animal Care and Use
Committee. The following lines were used: AB, Tuebingen,
cyp2R1 mutant, Tg(lmo2:dsred) (Zhu et al., 2005), Tg(cmyb:eGFP)
(North et al., 2007), Tg(flk1:dsRed2ex) (Kikuchi et al., 2011),
Tg(runx1P2:eGFP) (Lam et al., 2009), Tg(Gli-d:mCherry) (Schwend
et al., 2010), and Tg(EPV.Tp1CMmu.Hbb:EGFP) (Parsons et al.,
2009).
Chemical Treatments
Zebrafish embryos were exposed to chemical modulators in E3
fish medium from 12 to 36 hpf in multi-well plates. The following
compounds were used: D3 (50 mM, Enzo), 1,25(OH)D3 (10 mM,
Cayman Chemical), cyclopamine (50 mM, LC Laboratories),
20(S)-OHC (10 mM, Tocris), and SAG (10 mM, Tocris). Treated em-
bryos were analyzed by WISH using previously published probes
to runx1, cmyb, flk1, gfp, flt4, ephrinb2a, and ptc2 (Carroll et al.,
2014) and established methods (https://zfin.org/ZFIN/Methods/
ThisseProtocol.html). Data were qualitatively analyzed and graph-
ically depicted as the percentage falling into each of three pheno-
typic expression bins. ‘‘Medium’’ expression was set as the most
representative phenotype in the normal bell-curve distribution
of each cohort of controls (n R 3 replicate clutches). Images
were acquired using a Zeiss Axio Imager A1/AxioCam MRc using
AxioVision LE software.
MO and mRNA Injections
MOs (Gene Tools) were injected at the one-cell stage: cyp2r1MO1-
50-TGATCGATATCATCTTAGATGCAAA-03, cyp2r1MO2-50-TTCCA
TAAGGAACCACTTACCTCCC-30, cyb27b1MO-50-TGAAGCACCA
TCATCATCCTCCTGC-30, and vdraMO-50-ACGGCACTATTTTCCG
TAAGCATCC-30. Splicing efficiency of the cyp2r1 MO was deter-
mined by qRT-PCR using the following primer set: Cyp2r1Fwd-50-
ATGATATCGATCAAACGCTTAACATCACCG-30 and Cyp2r1Rev-
50-CAGAAATCCTCACAAACATCCTCCGCTGGC-30. SpecificityStem Cellwas tested by injection of in vitro transcribed full-length cyp2r1
mRNA (100 ng/ml). Synthesis was performed using mMessage
mMachine T7 and the Poly(A) Tailing Kit (Life Technologies).Embryo Dissociation and FACS Analysis
Fluorescent embryos (5 embryos/sample3 4 replicates/condition)
were incubated in 0.5 mg/ml of Liberase (Roche) with gentle agita-
tion at 37C for 2 hr and then manually dissociated by pipetting,
filtered, washed, and resuspended in 13 PBS. Samples were treated
with SYTOX Red dead cell stain (5 nM, Life Technologies) and
analyzed using a BD Biosciences FACSCanto II and LSRII 5 SORP.
Data were processed on Flojo X software (Tree Star), and statistics
(two-tailed Student’s t test) were performed using Prism 6
(GraphPad).qRT-PCR Performance
Total RNA (40 pooled embryos/condition) was purified using
the RNAqueous Total RNA isolation kit, followed by DNase-I
treatment, and used to generate cDNA using the Superscript
III First Strand Synthesis Supermix (Life Technologies). qRT-
PCR was performed using SYBR Green PCR Master Mix
(Life Technologies) on a Bio-Rad CFX384. Samples were run
in triplicate with >2 biological replicates/condition using
primer sequences in Table S1. RT-PCR Miner (http://ewindup.
info/miner/) was used for analysis, with statistics as explained
earlier.Cyp2r1 Mutation Generation and Validation
Guide RNA (gRNA) targeting cyp2r1 was designed using
Zifit Targeter (http://zifit.partners.org). Oligos to the cyp2r1 gRNA
sequence 50-GGACTTCTGAACTGCAAATA-30 were annealed,
cloned into pT7-gRNA (Addgene #46759), and in vitro transcribed
usingMEGAshortscript-T7 (Life Technologies). Cas9 RNA (100ng),
transcribed from pT3Ts-nls-zCas9-nls (Addgene #46757) using
mMessage mMachine T3, as explained earlier, was co-injected
with gRNA-cyp2r1 (50 ng) at the one-cell stage and raised to adult-
hood. cyp2r1-F1 mutants were identified by PCR amplification
flanking the target sequence: Cyp2r1CrispF-50-ATTGCTGTTT
GACCAGTCATCCCTGATCGA-30, Cyp2r1CrispR-50-CAGGGGAA
GGCGTTGTACAGGAAAGCCCAA-30, and EagI (NEB) restriction
digest. DNA sequencing confirmed the mutant cyp2r1 allele.
SUPPLEMENTAL INFORMATION
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